ViaDerma Inc VDRM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–0.02
- Bid/Ask
- $0.01 / $0.01
- Market Cap
- $1,373.22
- Volume/Avg
- 278,186 / 1.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 75
- Website
- https://www.viaderma.com
Valuation
Metric
|
VDRM
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
VDRM
|
---|---|
Quick Ratio | 1.95 |
Current Ratio | 2.15 |
Interest Coverage | 5.54 |
Quick Ratio
No chart available
Profitability
Metric
|
VDRM
|
---|---|
Return on Assets (Normalized) | 5.33% |
Return on Equity (Normalized) | 6.91% |
Return on Invested Capital (Normalized) | 6.92% |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Vqgnswpxwd | Ybrx | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Tmdpfgjj | Vnpzwpl | $70.9 Bil | |
HLN
| Haleon PLC ADR | Dvfpjqg | Tccg | $37.8 Bil | |
VTRS
| Viatris Inc | Knjbrdnj | Fmqps | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Csjxdyks | Jmxzm | $12.7 Bil | |
CTLT
| Catalent Inc | Kbwjcrdd | Zcyckgs | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Dbhdtdb | Yrny | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Jpngvyyf | Gzk | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ckdwvrxk | Ysqvqz | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Fygkbwhspw | Fdkd | $3.1 Bil |